Not Tagged
renovorx
['renovorx']
new positive ph. iii interim analysis data presented at the 2023 #wcgic2023 demonstrated an 8-month median pfs benefit, 15 vs. 7 months, in delaying the progression of cancer for patients receiving treatment with renovogem versus standard-of-care. $rnxt 
RenovoRx is fighting cancer through the localized treatment of difficult-to-treat tumors via its proprietary RenovoTAMP™ therapy platform.  Nasdaq: $RNXT